178 related articles for article (PubMed ID: 15754389)
1. Expression of cyclooxygenase-2 in colorectal cancer and its clinical significance.
Xiong B; Sun TJ; Hu WD; Cheng FL; Mao M; Zhou YF
World J Gastroenterol; 2005 Feb; 11(8):1105-8. PubMed ID: 15754389
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 expression and angiogenesis in colorectal cancer.
Xiong B; Sun TJ; Yuan HY; Hu MB; Hu WD; Cheng FL
World J Gastroenterol; 2003 Jun; 9(6):1237-40. PubMed ID: 12800231
[TBL] [Abstract][Full Text] [Related]
3. Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasis.
Soumaoro LT; Uetake H; Takagi Y; Iida S; Higuchi T; Yasuno M; Enomoto M; Sugihara K
Dis Colon Rectum; 2006 Mar; 49(3):392-8. PubMed ID: 16474989
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 expression as a new marker for patients with colorectal cancer.
Yamauchi T; Watanabe M; Kubota T; Hasegawa H; Ishii Y; Endo T; Kabeshima Y; Yorozuya K; Yamamoto K; Mukai M; Kitajima M
Dis Colon Rectum; 2002 Jan; 45(1):98-103. PubMed ID: 11786771
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 promotes angiogenesis by increasing vascular endothelial growth factor and predicts prognosis in gallbladder carcinoma.
Zhi YH; Liu RS; Song MM; Tian Y; Long J; Tu W; Guo RX
World J Gastroenterol; 2005 Jun; 11(24):3724-8. PubMed ID: 15968728
[TBL] [Abstract][Full Text] [Related]
6. Expression of cyclooxygenase-1 and -2 associated with expression of VEGF in primary cervical cancer and at metastatic lymph nodes.
Kim MH; Seo SS; Song YS; Kang DH; Park IA; Kang SB; Lee HP
Gynecol Oncol; 2003 Jul; 90(1):83-90. PubMed ID: 12821346
[TBL] [Abstract][Full Text] [Related]
7. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K
Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629
[TBL] [Abstract][Full Text] [Related]
8. Involvement of cyclooxygenase-2 and vascular endothelial growth factor in vascularization and lymph node metastasis of colorectal cancers with submucosal invasion.
Abe A; Fukui H; Fujii S; Fujita M; Mukawa K; Ichikawa K; Tomita S; Ono Y; Imai Y; Imura J; Kubota K; Fujimori T
J Gastroenterol Hepatol; 2007 Jul; 22(7):1071-7. PubMed ID: 17608853
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer.
Cianchi F; Cortesini C; Bechi P; Fantappiè O; Messerini L; Vannacci A; Sardi I; Baroni G; Boddi V; Mazzanti R; Masini E
Gastroenterology; 2001 Dec; 121(6):1339-47. PubMed ID: 11729113
[TBL] [Abstract][Full Text] [Related]
10. [Effect of cyclooxygenase-2,and matrix metalloproteinase-2 expression on prognosis of lung cancer].
Zhang HZ; Lu ZQ; Xie DR; Li HG; Xiong LH; Zhang H; Chen XB
Ai Zheng; 2004 Oct; 23(10):1190-3. PubMed ID: 15473933
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer.
Soumaoro LT; Uetake H; Higuchi T; Takagi Y; Enomoto M; Sugihara K
Clin Cancer Res; 2004 Dec; 10(24):8465-71. PubMed ID: 15623626
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma.
Shi H; Xu JM; Hu NZ; Xie HJ
World J Gastroenterol; 2003 Jul; 9(7):1421-6. PubMed ID: 12854133
[TBL] [Abstract][Full Text] [Related]
13. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
[TBL] [Abstract][Full Text] [Related]
14. A multivariate analysis of prognostic determinants for stages II and III colorectal cancer in 141 patients.
Zhou ZG; Wu XJ; Li LR; Peng ZH; Ding PR; Wang RJ; Pan ZZ
Chin Med J (Engl); 2011 Jul; 124(14):2132-5. PubMed ID: 21933615
[TBL] [Abstract][Full Text] [Related]
15. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.
Yuan A; Yu CJ; Shun CT; Luh KT; Kuo SH; Lee YC; Yang PC
Int J Cancer; 2005 Jul; 115(4):545-55. PubMed ID: 15704107
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of vascular endothelial growth factor-C and cyclooxygenase-2 in esophageal squamous cell carcinoma.
Byeon JS; Jung HY; Lee YJ; Lee D; Lee GH; Myung SJ; Yang SK; Hong WS; Kim JH; Min YI; Kim JS
J Gastroenterol Hepatol; 2004 Jun; 19(6):648-54. PubMed ID: 15151619
[TBL] [Abstract][Full Text] [Related]
17. Role of COX-2, VEGF and cyclin D1 in mammary infiltrating duct carcinoma.
Lim SC
Oncol Rep; 2003; 10(5):1241-9. PubMed ID: 12883688
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 expression correlates with uPAR levels and is responsible for poor prognosis of colorectal cancer.
Konno H; Baba M; Shoji T; Ohta M; Suzuki S; Nakamura S
Clin Exp Metastasis; 2002; 19(6):527-34. PubMed ID: 12405290
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclooxygenase-2 protein in colorectal carcinomas.
Joo YE; Kim HS; Min SW; Lee WS; Park CH; Park CS; Choi SK; Rew JS; Kim SJ
Int J Gastrointest Cancer; 2002; 31(1-3):147-54. PubMed ID: 12622426
[TBL] [Abstract][Full Text] [Related]
20. Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer.
Sivula A; Talvensaari-Mattila A; Lundin J; Joensuu H; Haglund C; Ristimäki A; Turpeenniemi-Hujanen T
Breast Cancer Res Treat; 2005 Feb; 89(3):215-20. PubMed ID: 15754118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
